Literature DB >> 30696720

Monod-Wyman-Changeux Allosteric Shift Analysis in Mutant α1β3γ2L GABAA Receptors Indicates Selectivity and Crosstalk among Intersubunit Transmembrane Anesthetic Sites.

Andrea Szabo1, Anahita Nourmahnad1, Elizabeth Halpin1, Stuart A Forman2.   

Abstract

Propofol, etomidate, and barbiturate anesthetics are allosteric coagonists at pentameric α1β3γ2 GABAA receptors, modulating channel activation via four biochemically established intersubunit transmembrane pockets. Etomidate selectively occupies the two β +/α - pockets, the barbiturate photolabel R-5-allyl-1-methyl-5-(m-trifluoromethyl-diazirynylphenyl) barbituric acid (R-mTFD-MPAB) occupies homologous α +/β - and γ +/β - pockets, and propofol occupies all four. Functional studies of mutations at M2-15' or M3-36' loci abutting these pockets provide conflicting results regarding their relative contributions to propofol modulation. We electrophysiologically measured GABA-dependent channel activation in α1β3γ2L or receptors with single M2-15' (α1S270I, β3N265M, and γ2S280W) or M3-36' (α1A291W, β3M286W, and γ2S301W) mutations, in the absence and presence of equipotent clinical range concentrations of etomidate, R-mTFD-MPAB, and propofol. Estimated open probabilities were calculated and analyzed using global two-state Monod-Wyman-Changeux models to derive log(d) parameters proportional to anesthetic-induced channel modulating energies (where d is the allosteric anesthetic shift factor). All mutations reduced the log(d) values for anesthetics occupying both abutting and nonabutting pockets. The Δlog(d) values [log(d, mutant) - log(d, wild type)] for M2-15' mutations abutting an anesthetic's biochemically established binding sites were consistently larger than the Δlog(d) values for nonabutting mutations, although this was not true for the M3-36' mutant Δlog(d) values. The sums of the anesthetic-associated Δlog(d) values for sets of M2-15' or M3-36' mutations were all much larger than the wild-type log(d) values. Mutant Δlog(d) values qualitatively reflect anesthetic site occupancy patterns. However, the lack of Δlog(d) additivity undermines quantitative comparisons of distinct site contributions to anesthetic modulation because the mutations impaired both abutting anesthetic binding effects and positive cooperativity between anesthetic binding sites.
Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30696720      PMCID: PMC6399575          DOI: 10.1124/mol.118.115048

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  39 in total

1.  Allosteric activation mechanism of the alpha 1 beta 2 gamma 2 gamma-aminobutyric acid type A receptor revealed by mutation of the conserved M2 leucine.

Authors:  Y Chang; D S Weiss
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

2.  The Actions of Drug Combinations on the GABAA Receptor Manifest as Curvilinear Isoboles of Additivity.

Authors:  Daniel J Shin; Allison L Germann; Joe Henry Steinbach; Gustav Akk
Journal:  Mol Pharmacol       Date:  2017-08-08       Impact factor: 4.436

3.  Mutations in the GABAA receptor that mimic the allosteric ligand etomidate.

Authors:  Stuart A Forman; Deirdre Stewart
Journal:  Methods Mol Biol       Date:  2012

4.  High Constitutive Activity Accounts for the Combination of Enhanced Direct Activation and Reduced Potentiation in Mutated GABAA Receptors.

Authors:  Allison L Germann; Daniel J Shin; Christina R Kuhrau; Alexander D Johnson; Alex S Evers; Gustav Akk
Journal:  Mol Pharmacol       Date:  2018-02-08       Impact factor: 4.436

Review 5.  Monod-Wyman-Changeux allosteric mechanisms of action and the pharmacology of etomidate.

Authors:  Stuart A Forman
Journal:  Curr Opin Anaesthesiol       Date:  2012-08       Impact factor: 2.706

6.  Propofol and other intravenous anesthetics have sites of action on the gamma-aminobutyric acid type A receptor distinct from that for isoflurane.

Authors:  M D Krasowski; V V Koltchine; C E Rick; Q Ye; S E Finn; N L Harrison
Journal:  Mol Pharmacol       Date:  1998-03       Impact factor: 4.436

7.  Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the human α1β3γ2 γ-aminobutyric acid type A (GABAA) receptor.

Authors:  David C Chiara; Selwyn S Jayakar; Xiaojuan Zhou; Xi Zhang; Pavel Y Savechenkov; Karol S Bruzik; Keith W Miller; Jonathan B Cohen
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

8.  Gating allosterism at a single class of etomidate sites on alpha1beta2gamma2L GABA A receptors accounts for both direct activation and agonist modulation.

Authors:  Dirk Rüsch; Huijun Zhong; Stuart A Forman
Journal:  J Biol Chem       Date:  2004-03-11       Impact factor: 5.157

Review 9.  Combining Mutations and Electrophysiology to Map Anesthetic Sites on Ligand-Gated Ion Channels.

Authors:  Stuart A Forman
Journal:  Methods Enzymol       Date:  2018-02-28       Impact factor: 1.600

10.  Correction for Inhibition Leads to an Allosteric Co-Agonist Model for Pentobarbital Modulation and Activation of α1β3γ2L GABAA Receptors.

Authors:  Alexis M Ziemba; Stuart A Forman
Journal:  PLoS One       Date:  2016-04-25       Impact factor: 3.240

View more
  11 in total

1.  Binding site location on GABAA receptors determines whether mixtures of intravenous general anaesthetics interact synergistically or additively in vivo.

Authors:  Daniel E Kent; Pavel Y Savechenkov; Karol S Bruzik; Keith W Miller
Journal:  Br J Pharmacol       Date:  2019-12-11       Impact factor: 8.739

2.  Drug-selective Anesthetic Insensitivity of Zebrafish Lacking γ-Aminobutyric Acid Type A Receptor β3 Subunits.

Authors:  Xiaoxuan Yang; Youssef Jounaidi; Kusumika Mukherjee; Ryan J Fantasia; Eric C Liao; Buwei Yu; Stuart A Forman
Journal:  Anesthesiology       Date:  2019-12       Impact factor: 7.892

3.  Concatemers to re-investigate the role of α5 in α4β2 nicotinic receptors.

Authors:  Marie S Prevost; Hichem Bouchenaki; Nathalie Barilone; Marc Gielen; Pierre-Jean Corringer
Journal:  Cell Mol Life Sci       Date:  2020-05-29       Impact factor: 9.261

4.  Steady-State Activation and Modulation of the Concatemeric α1β2γ2L GABAA Receptor.

Authors:  Allison L Germann; Spencer R Pierce; Ariel B Burbridge; Joe Henry Steinbach; Gustav Akk
Journal:  Mol Pharmacol       Date:  2019-07-01       Impact factor: 4.436

5.  (+)-Catharanthine potentiates the GABAA receptor by binding to a transmembrane site at the β(+)/α(-) interface near the TM2-TM3 loop.

Authors:  Hugo R Arias; Cecilia M Borghese; Allison L Germann; Spencer R Pierce; Alessandro Bonardi; Alessio Nocentini; Paola Gratteri; Thanvi M Thodati; Natalie J Lim; R Adron Harris; Gustav Akk
Journal:  Biochem Pharmacol       Date:  2022-03-15       Impact factor: 6.100

6.  A potent photoreactive general anesthetic with novel binding site selectivity for GABAA receptors.

Authors:  Abdelrahman R Shalabi; Zhiyi Yu; Xiaojuan Zhou; Youssef Jounaidi; Hanwen Chen; Jiajia Dai; Daniel E Kent; Hua-Jun Feng; Stuart A Forman; Jonathan B Cohen; Karol S Bruzik; Keith W Miller
Journal:  Eur J Med Chem       Date:  2020-03-23       Impact factor: 6.514

7.  Selective actions of benzodiazepines at the transmembrane anaesthetic binding sites of the GABAA receptor: In vitro and in vivo studies.

Authors:  Megan McGrath; Helen Hoyt; Andrea Pence; Stuart A Forman; Douglas E Raines
Journal:  Br J Pharmacol       Date:  2021-09-26       Impact factor: 8.739

8.  Intrasubunit and Intersubunit Steroid Binding Sites Independently and Additively Mediate α1β2γ2L GABAA Receptor Potentiation by the Endogenous Neurosteroid Allopregnanolone.

Authors:  Allison L Germann; Spencer R Pierce; Hiroki Tateiwa; Yusuke Sugasawa; David E Reichert; Alex S Evers; Joe Henry Steinbach; Gustav Akk
Journal:  Mol Pharmacol       Date:  2021-05-06       Impact factor: 4.054

9.  Substituted Cysteine Modification and Protection with n-Alkyl- Methanethiosulfonate Reagents Yields a Precise Estimate of the Distance between Etomidate and a Residue in Activated GABA Type A Receptors.

Authors:  Ryan J Fantasia; Anahita Nourmahnad; Elizabeth Halpin; Stuart A Forman
Journal:  Mol Pharmacol       Date:  2021-03-25       Impact factor: 4.054

10.  Steady-state activation and modulation of the synaptic-type α1β2γ2L GABAA receptor by combinations of physiological and clinical ligands.

Authors:  Allison L Germann; Spencer R Pierce; Thomas C Senneff; Ariel B Burbridge; Joe Henry Steinbach; Gustav Akk
Journal:  Physiol Rep       Date:  2019-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.